The largest database of trusted experimental protocols

22 protocols using sictrl

1

Silencing GPR109a in IPEC-J2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
GPR109a-specific siRNA1 (CGATGTTAATCAAGAAGCA), siRNA2 (GTAGCTTCAGCAT CTGCAA), and negative control siRNA (siCtrl) (RiboBio, Guangzhou, china) were used to knockdown GPR109a. The si-GPR109a and siCtrl were transfected into IPEC-J2 using lipofectamine 3000 (Invitrogen, USA) following the manufacturer’s procedures.
+ Open protocol
+ Expand
2

Targeting TAK1 and NRF2 with siRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Effective siRNA oligonucleotides targeting TAK1 and NRF2 were obtained from RiboBio with the following sequences:
siTAK1-#1: GGAGTGGCTTATCTTCACA;
siTAK1-#2: GGCTTATCTTACACTGGAT;
siNRF2-1#: GAGAAAGAATTGCCTGTAA;
siNRF2-2#: GCTACGTGATGAAGATGGA;
siNRF2-3#: GCCCTCACCTGCTACTTTA.
The negative control (siCtrl) was nonhomologous to any human genome sequence and purchased from RiboBio Co., Ltd. Predetermined cells were grown in 6-well plates for 12 h and then transfected with 20 nM siRNA mixed with 5 μL of Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions. Thirty-six to 48 h after transfection, the cells were harvested for further analysis.
Total RNA was extracted using TRIzol (Life Technology), reverse transcribed into cDNA using the GoScriptTM Reverse Transcription System (Promega) and analyzed by real-time qPCR on a BIO-RAD Real-time PCR machine using iTaq™ Universal SYBR® Green Super mix (Bio–Rad). The results were normalized to β-actin, and relative values were calculated using the 2[-(CT gene -CT reference)] method. The gene-specific primers used for qPCR are listed in Supplementary Table 3.
+ Open protocol
+ Expand
3

Knockdown of Foxf1 Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Foxf1-specific siRNAs (GTGTGACCGAAAGGAGTTT for human and GATCCGGCTAGCGAGTTTA for mouse) and negative control siRNA (siCtrl) (RiboBio, Guangzhou, China) were used to knockdown Foxf1. Transfection of siRNA oligonucleotides was performed using Lipofectamine RNAimax (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Foxf1 expression was determined by quantitative reverse transcription PCR (qRT-PCR), western blotting (WB), and immunofluorescence (IF). Transfected cells were passaged and used for downstream analyses.
+ Open protocol
+ Expand
4

Snail Gene Silencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNA duplex oligonucleotides targeting human Snail mRNA (sense: 5′-GGACACAGGUUCUGAAACA-3′ and anti-sense: 5′-CCUGUGUCCAAGACUUUGU-3′) and the sequence of si-negative control (si-ctrl) were designed by RiboBio (Guangzhou, China). pcDNA.3-Snail was a kind gift from Dr Ming Li (Sun Yat-Sen University, Guangzhou, China). Oligonucleotide transfection was performed with Lipofectamine 2000 reagent (Thermo Fisher Scientific).
+ Open protocol
+ Expand
5

siRNA-mediated Knockdown of LncRNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three independent siRNAs against TUC339 and lincRNA-VLDLR along with unrelated control siRNA (si-ctrl) were purchased from Ribobio (Guangzhou, China). THP-1 cells were transfected with 50 nM siRNA to lncRNA or si-ctrl using INTERFERin (Polyplus-transfection SA, Illkirch-Graffenstaden, France) for 48 h before further experiments. si-TUC339-1 was used in functional studies.
+ Open protocol
+ Expand
6

Overexpression and Silencing of SENCR in VSMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full length mouse SENCR cDNA was cloned into pcDNA-3.1 vector and stored in -20°C. Small interfering RNA (siRNA) against SENCR (si-SENCR) or siRNA negative control (si-NC, si-Ctrl) were designed and purchased from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). Next, pcDNA-SENCR (2 μg), empty vector (2 μg), si-SENCR (50 nM), and si-NC (50 nM) were transfected into Ang-II-induced VSMCs using Lipofectamine® 2000 (Invitrogen).
+ Open protocol
+ Expand
7

Targeted siRNA Knockdown Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three different siRNAs, namely anti-RACGAP1 (si-RACGAP1-1/-2/-3) and control siRNA (si-Ctrl), were purchased from Ribobio (Guangzhou, Guangdong, China). Cells were transfected with siRNAs or si-Ctrl at a concentration of 100 nM using Lipofectamine RNAiMax (Thermo Fisher Scientific) for 6–8 h according to manufacturer’s instructions. The cells were then cultured with complete medium at 37℃ in a humidified atmosphere with 5% CO2 for the indicated time points prior to use for experiments.
+ Open protocol
+ Expand
8

Plasmid and siRNA Transfection in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were cultured in a 6-well or 24-well plate for 24 hours and then were transfected with plasmids or siRNAs. All transfections were performed using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. siRNA oligonucleotides, including targeting HULC (or CLOCK) and a nonspecific scrambled control (si-Ctrl), were synthesized by RiboBio (Guangzhou, China). The siRNA duplexes sequences are all listed in Supplementary Table S1.
+ Open protocol
+ Expand
9

IGF-1R Regulation via miR-944 and Plasmid Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-944 mimics, a miR-944 inhibitor, negative control miRNA mimics (miR-NC), and a negative control miRNA inhibitor (NC inhibitor) were provided by Shanghai GenePharma Co., Ltd. (Shanghai, China). A small interfering RNA (siRNA) used to knockdown IGF-1R expression (si-IGF-1R) and a control siRNA (si-ctrl) were chemically synthesized by Guangzhou RiboBio Co., Ltd. (Guangzhou, China).
The pcDNA3.1-IGF-1R (pc-IGF-1R) plasmid was employed to increase the expression of IGF-1R and an empty pcDNA3.1 plasmid was used as a control. Plasmids were chemically synthesized by the Chinese Academy of Sciences (Changchun, China).
For transfection, cells were plated into 6-well plates. Transfection was performed when the cells had grown to approximately 60–70% density. Lipofectamine™ 2000 (Invitrogen; Thermo Fisher Scientific) was used for transfections and assays were performed according to the product specifications. After 8 h of culture, culture medium was replaced with fresh DMEM containing 10% FBS.
+ Open protocol
+ Expand
10

Transient and Lentiviral Transfection of SRSF9, DSN1, and METTL3

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transient transfection, small interfering RNAs (siRNAs) directed against SRSF9 (#SIGS0008682-4, RIBOBIO, Guangzhou, China), DSN1 (#SIGS0013609-1, RIBOBIO), METTL3 (#SIGS00056532-1, RIBOBIO) and negative control RNAs (si-ctrl) were synthesized by RIBOBIO Company (Guangzhou, China). Transient transfection was performed using a Hieff Trans™ Liposomal Transfection Reagent kit (#40802, Yeasen, Shanghai, China) in accordance with the standard protocol. Cells were collected after 24 h for qRT-PCR and after 48 h for Western blotting and functional studies.
For lentiviral transfection, Flag-SRSF9 (ov-SRSF9), empty vector (Vector), shSRSF9 (sh1, sh2), and shNC were purchased from GeneChem Company (Shanghai, China). Caco2 cells and HT29 cells were used to establish stable SRSF9 overexpression models, and HCT116 cells and LOVO cells were used in the stable SRSF9 knockdown experiments. According to the manufacturer’s instructions, 4 × 104 cells per well were seeded and transfected with the indicated lentiviruses. The infected cells were screened using 5 μg/mL puromycin (Solarbio, Beijing, China) for 1 week or longer, and transfection efficiency was determined by qRT-PCR and Western blotting analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!